Expands high entry barrier portfolio; Leadership in Women’s Health (#1 in Gynae IPM[i]) High entry barrier portfolio with specialty R&D tech platforms across - Recombinants, Niche Biologics, Novel Delivery and Immunoglobulins Only innovator in the world to develop patented recombinant Anti-D Brands across Women’s Health